Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec 25;9(12):6102-6110.
doi: 10.19082/6102. eCollection 2017 Dec.

Exploring Iranian β-Thalassemia major patients' perception of barriers and facilitators of adherence to treatment: A qualitative study

Amir Emami Zeydi  1 , Hossein Karimi Moonaghi  2 , Abbas Heydari  2
Affiliations

Exploring Iranian β-Thalassemia major patients' perception of barriers and facilitators of adherence to treatment: A qualitative study

Amir Emami Zeydi et al. Electron Physician. .

Abstract

Background: Despite the clinical importance of adherence to treatment in β-Thalassemia Major (β-TM) patients, poor adherence remains a prevalent and persistent problem in these patients.

Objective: The aim of this study was to explore Iranian β-TM patients' perception regarding the barriers and facilitators of adherence to their treatments.

Methods: In this qualitative study, data were collected using purposeful sampling and semi-structured interviews with 18 β-TM patients, 3 family members and 5 healthcare professionals (total=26) in Sari, northern Iran, between August 2015 and May 2017. Data were analyzed using conventional content analysis with the support of MAXQDA software. All the interviews were transcribed verbatim. Data were coded and grouped under specific categories.

Results: We identified and classified the perceived barriers of patients' adherence to treatment into six main categories including: (I) long distance challenges, (II) delayed occurrence of complications, (III) fatigue of healthcare providers, (IV) staff workload, (V) insufficient follow-up of healthcare workers, and (VI) busy everyday life. Also, nine main categories emerged as facilitators including: (I) concern of appearance changing, (II) outcomes of treatment, (III) good awareness, (IV) parental monitoring, (V) fear of complications, (VI) social activity, (VII) marriage as a facilitator, (VIII) friendly interaction with the medical staff, and (IX) trusting the medical staff.

Conclusion: Our findings provide a broad range of context-specific facilitators and barriers to treatment adherence perceived by Iranian β-TM patients. These factors improve our understanding of the complex and multifactorial nature of adherence to treatments. Health care providers can use these findings in designing and implementing appropriate interventions to promote β-TM patients' adherence to treatment.

Keywords: Beta-Thalassemia; Medication adherence; Patient compliance; Qualitative research.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: All authors declare no conflict of interest; no conflict of interest exists for any of the authors associated with the manuscript. The funding organization had no role in the design and conduct of the study, or in the collection, analysis, and interpretation of the data.

References

    1. Mednick L, Yu S, Trachtenberg F, Xu Y, Kleinert DA, Giardina PJ, et al. Symptoms of depression and anxiety in patients with thalassemia: prevalence and correlates in the thalassemia longitudinal cohort. Am J Hematol. 2010;85(10):802–5. doi: 10.1002/ajh.21826. - DOI - PMC - PubMed
    1. Darvishi Khezri H, Emami Zeydi A, Sharifi H, Jalali H. Is Vitamin C Supplementation in Patients with beta-Thalassemia Major Beneficial or Detrimental? Hemoglobin. 2016;40(4):293–4. doi: 10.1080/03630269.2016.1190373. - DOI - PubMed
    1. Dehshal MH. Addressing adherence to treatment: a longstanding concern. The patients’ perspective. Thalassemia Reports. 2014;4(3) doi: 10.1080/03630269.2016.1190373. - DOI - PubMed
    1. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26(5):331–42. doi: 10.1046/j.1365-2710.2001.00363.x. - DOI - PubMed
    1. Pedram M, Zandian K, Keikhaie B, Akramipour R, Hashemi A, Ghahfarokhi FK, et al. A report on chelating therapy and patient compliance by determination of serum ferritin levels in 243 thalassemia major patients. Iranian J Pediatr Soc. 2010;2(2):65–9.

LinkOut - more resources